Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna GTN provision related to sales made in current period by Quarter
GTN provision related to sales made in current period ($M) ($M)
Moderna GTN provision related to sales made in current period: $14M in Q2 2026, down 12.5% from a year earlier.
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 10-Q (filed 2026-07-31) ↗
Reported in Form 10-Q / 10-K Note 2 (Sales Returns Reserve Rollforward).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GTN provision related to sales made in current period ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 14 | -12.5% | Form 10-Q (filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 9 | +12.5% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 237 | +100.8% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 175 | – | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 16 | – | Form 10-Q (filed 2025-08-01) ↗ |
| Q1 2025 | Mar 31, 2025 | 8 | – | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 118 | – | Form 10-K (filed 2025-02-21) ↗ |
Cite this data
StockData. (2026). Moderna GTN provision related to sales made in current period ($M), quarterly Q4 2024–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/gtn-prov-cur-yr
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.